Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis

The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00184964

Enrollment

Registered

2005-09-16

Start date

2004-06-30

Completion date

Unknown

Last updated

2008-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Non Small Cell Lung

Brief summary

CT-PET image fusion has the potential to differentiate 'tumor' from 'atelectasis' much better than the CT-scan in patients with non-small cell lung cancer who also have atelectasis. This however has never been validated on a histological level. In this study patients with non small cell lung cancer and atelectasis who are eligible for surgery undergo a CT-scan and a PET-scan prior to surgery. The resection specimen will be compared to the preoperative imaging.

Interventions

PROCEDURECT-scan, PET-scan

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

-Patients with non small cell lung cancer and atelectasis, who are eligible for surgery.

Exclusion criteria

* age \< 18 years * pregnancy

Design outcomes

Primary

Measure	Time frame
Histological validation of CT-PET image fusion.	—

Countries

Netherlands

Contacts

Primary ContactDominic A Schinagl, MD

d.schinagl@rther.umcn.nl+31243614515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026